XML 126 R113.htm IDEA: XBRL DOCUMENT v3.25.1
REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Equity (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period $ 3,423 $ 3,339 $ 3,715 $ 4,375 $ 5,259 $ 5,493 $ 4,375 $ 3,168 $ 4,375 $ 3,168 $ 4,375 $ 3,168 $ 11,920
Net income (loss) 147     177                  
Other comprehensive income (loss) 1,158 2,083 (482) (398) (2,705) (625) (880) 1,831 1,203 (874) (917) 1,204 (10,252)
Balance, end of period 4,205 4,956 3,339 3,715 3,226 5,259 3,339 5,259 4,956 3,226 3,423 4,375 3,168
Total Holdings Equity                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period 1,565 1,598 1,992 2,636 3,552 3,753 2,636 1,428 2,636 1,428 2,636 1,428 10,344
Net income (loss) 63     92                  
Other comprehensive income (loss) 1,145     (394)                  
Balance, end of period 2,401 3,201 1,598 1,992 1,587 3,552 1,598 3,552 3,201 1,587 1,565 2,636 1,428
Retained Earnings                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period 10,627 10,301 10,095 10,250 10,347 9,827 10,250 9,851 10,250 9,851 10,250 9,851 8,453
Net income (loss) 63 (132) 428 92 1,048 760 520 932 388 1,980 1,280 1,283 2,140
Other comprehensive income (loss) 0     0                  
Balance, end of period 10,447 9,964 10,301 10,095 11,169 10,347 10,301 10,347 9,964 11,169 10,627 10,250 9,851
Accumulated Other Comprehensive Income (Loss)                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period (8,712) (8,675) (8,191) (7,797) (7,165) (6,538) (7,797) (8,991) (7,797) (8,991) (7,797) (8,991) 1,245
Net income (loss) 0     0                  
Other comprehensive income (loss) 1,145 2,074 (484) (394) (2,698) (627) (878) 1,826 1,196 (872) (915) 1,194 (10,236)
Balance, end of period (7,567) (6,601) (8,675) (8,191) (9,863) (7,165) (8,675) (7,165) (6,601) (9,863) (8,712) (7,797) (8,991)
As Previously 
Reported                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period 3,443 3,385 3,755 4,388 5,260 5,471 4,388 3,141 4,388 3,141 4,388 3,141 11,927
Other comprehensive income (loss)   2,058 (476) (393) (2,667) (623) (869) 1,855 1,189 (812) (937) 1,225 (10,311)
Balance, end of period   4,975 3,385 3,755 3,281 5,260 3,385 5,260 4,975 3,281 3,443 4,388 3,141
As Previously 
Reported | Total Holdings Equity                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period 1,585 1,644 2,032 2,649 3,553 3,754 2,649 1,401 2,649 1,401 2,649 1,401 10,351
Balance, end of period   3,220 1,644 2,032 1,642 3,553 1,644 3,553 3,220 1,642 1,585 2,649 1,401
As Previously 
Reported | Retained Earnings                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period 10,647 10,317 10,110 10,243 10,325 9,806 10,243 9,825 10,243 9,825 10,243 9,825 8,413
Net income (loss)   (134) 428 114 1,064 759 542 936 408 2,000 1,307 1,302 2,153
Balance, end of period   9,977 10,317 10,110 11,163 10,325 10,317 10,325 9,977 11,163 10,647 10,243 9,825
As Previously 
Reported | Accumulated Other Comprehensive Income (Loss)                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period (8,712) (8,645) (8,166) (7,777) (7,142) (6,516) (7,777) (8,992) (7,777) (8,992) (7,777) (8,992) 1,303
Other comprehensive income (loss)   2,050 (479) (389) (2,660) (626) (868) 1,850 1,182 (810) (935) 1,215 (10,295)
Balance, end of period   (6,595) (8,645) (8,166) (9,802) (7,142) (8,645) (7,142) (6,595) (9,802) (8,712) (7,777) (8,992)
Impact of Revisions                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period (20) (46) (40) (13) (1) 22 (13) 27 (13) 27 (13) 27 (7)
Other comprehensive income (loss)   25 (6) (5) (38) (2) (11) (24) 14 (62) 20 (21) 59
Balance, end of period   (19) (46) (40) (55) (1) (46) (1) (19) (55) (20) (13) 27
Impact of Revisions | Total Holdings Equity                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period (20) (46) (40) (13) (1) (1) (13) 27 (13) 27 (13) 27 (7)
Balance, end of period   (19) (46) (40) (55) (1) (46) (1) (19) (55) (20) (13) 27
Impact of Revisions | Retained Earnings                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period (20) (16) (15) 7 22 21 7 26 7 26 7 26 40
Net income (loss)   2 0 (22) (16) 1 (22) (4) (20) (20) (27) (19) (13)
Balance, end of period   (13) (16) (15) 6 22 (16) 22 (13) 6 (20) 7 26
Impact of Revisions | Accumulated Other Comprehensive Income (Loss)                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Balance, beginning of period $ 0 (30) (25) (20) (23) (22) (20) 1 (20) 1 (20) 1 (58)
Other comprehensive income (loss)   24 (5) (5) (38) (1) (10) (24) 14 (62) 20 (21) 59
Balance, end of period   $ (6) $ (30) $ (25) $ (61) $ (23) $ (30) $ (23) $ (6) $ (61) $ 0 $ (20) $ 1